Oncology targets, strategies, cancer drug development and personalized medicine
Website Use Notice and PDF printing help
Cancer Meetings and Conference Calendar
Mission Tumor's Cancer Charity of the Month DCCS
Thursday, November 3, 2011
MDV1300 Making a Mark While Provenge Takes a Deep Plunge
Today San Francisco-based
($MDVN) saw its stock value scale
within a day. This coming on the heels of
losing a huge chunk of its stock value
yesterday is a good example of human psychology.
We reward "optimism" over "cautious behavior."
Read more »
phase 3 trial